Baidu
map

Eur Urol Focus:根治性前列腺切除术中冷冻切片研究

2019-04-06 AlexYang MedSci原创

神经血管术(NVB)和神经血管术保留(NVBP)以及手术切缘状态是影响前列腺癌患者根治性切除术后功能和结果的主要术中影响因素。最近,有研究人员分析了NVBP术中执行冷冻切片技术(IFST)对NVB频率的影响以及对阳性手术切缘(PSMs)的影响。研究总共包括了346名患者。在这些患者中54.9%(n=190)经历了RP和IFST,45.1%的患者经历了RP而没有经历IFST。在NVBP期间进行了IF

神经血管术(NVB)和神经血管术保留(NVBP)以及手术切缘状态是影响前列腺癌患者根治性切除术后功能和结果的主要术中影响因素。最近,有研究人员分析了NVBP术中执行冷冻切片技术(IFST)对NVB频率的影响以及对阳性手术切缘(PSMs)的影响。

研究总共包括了346名患者。在这些患者中54.9%(n=190)经历了RP和IFST,45.1%的患者经历了RP而没有经历IFST。在NVBP期间进行了IFST后,研究发现,在整个群体中(pT2:14.6% vs 8.6%;pT3:47.1% vs 29.4%)PSM从29.5%减少到了15.4%(p=0.003)。相反地,在整个群体中(pT2:68.9% vs 99.0%; pT3:39.1% vs 88.2%)NVBP从55.3%增加到了95.5%(p<0.001)。在多变量逻辑回归分析中,在控制了患者和肿瘤特性后,IFST使用时PSMs的一个独立预测因子(风险比(OR):0.54,95%置信区间(CI):0.30-0.98; p=0.047),同时也是NVBP(OR: 5.60, 95% CI: 3.10-10.51; p<0.001)的一个独立预测因子。

最后,研究人员指出,与不进行IFST比较,在NVBP期间执行IFST能够导致NVBP频率变高,并且与更低的PSM相关。因此,研究人员最后建议在术中推荐进行IFST。

原始出处:


本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1877139, encodeId=9a3a18e713929, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Sun Jan 12 20:23:00 CST 2020, time=2020-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1708847, encodeId=855b1e0884779, content=<a href='/topic/show?id=ffca32501e6' target=_blank style='color:#2F92EE;'>#前列腺切除#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32501, encryptionId=ffca32501e6, topicName=前列腺切除)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbe731571573, createdName=1249898am25暂无昵称, createdTime=Fri May 10 21:23:00 CST 2019, time=2019-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1664860, encodeId=ae51166486072, content=<a href='/topic/show?id=c2ec311056b' target=_blank style='color:#2F92EE;'>#冷冻切片#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31105, encryptionId=c2ec311056b, topicName=冷冻切片)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bca925859708, createdName=41514495@qq.com, createdTime=Sat Oct 26 23:23:00 CST 2019, time=2019-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586135, encodeId=57871586135c2, content=<a href='/topic/show?id=38f8622191b' target=_blank style='color:#2F92EE;'>#根治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62219, encryptionId=38f8622191b, topicName=根治)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Apr 08 03:23:00 CST 2019, time=2019-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364215, encodeId=8ccb36421543, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Sat Apr 06 13:40:20 CST 2019, time=2019-04-06, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1877139, encodeId=9a3a18e713929, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Sun Jan 12 20:23:00 CST 2020, time=2020-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1708847, encodeId=855b1e0884779, content=<a href='/topic/show?id=ffca32501e6' target=_blank style='color:#2F92EE;'>#前列腺切除#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32501, encryptionId=ffca32501e6, topicName=前列腺切除)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbe731571573, createdName=1249898am25暂无昵称, createdTime=Fri May 10 21:23:00 CST 2019, time=2019-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1664860, encodeId=ae51166486072, content=<a href='/topic/show?id=c2ec311056b' target=_blank style='color:#2F92EE;'>#冷冻切片#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31105, encryptionId=c2ec311056b, topicName=冷冻切片)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bca925859708, createdName=41514495@qq.com, createdTime=Sat Oct 26 23:23:00 CST 2019, time=2019-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586135, encodeId=57871586135c2, content=<a href='/topic/show?id=38f8622191b' target=_blank style='color:#2F92EE;'>#根治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62219, encryptionId=38f8622191b, topicName=根治)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Apr 08 03:23:00 CST 2019, time=2019-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364215, encodeId=8ccb36421543, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Sat Apr 06 13:40:20 CST 2019, time=2019-04-06, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1877139, encodeId=9a3a18e713929, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Sun Jan 12 20:23:00 CST 2020, time=2020-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1708847, encodeId=855b1e0884779, content=<a href='/topic/show?id=ffca32501e6' target=_blank style='color:#2F92EE;'>#前列腺切除#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32501, encryptionId=ffca32501e6, topicName=前列腺切除)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbe731571573, createdName=1249898am25暂无昵称, createdTime=Fri May 10 21:23:00 CST 2019, time=2019-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1664860, encodeId=ae51166486072, content=<a href='/topic/show?id=c2ec311056b' target=_blank style='color:#2F92EE;'>#冷冻切片#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31105, encryptionId=c2ec311056b, topicName=冷冻切片)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bca925859708, createdName=41514495@qq.com, createdTime=Sat Oct 26 23:23:00 CST 2019, time=2019-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586135, encodeId=57871586135c2, content=<a href='/topic/show?id=38f8622191b' target=_blank style='color:#2F92EE;'>#根治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62219, encryptionId=38f8622191b, topicName=根治)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Apr 08 03:23:00 CST 2019, time=2019-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364215, encodeId=8ccb36421543, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Sat Apr 06 13:40:20 CST 2019, time=2019-04-06, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1877139, encodeId=9a3a18e713929, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Sun Jan 12 20:23:00 CST 2020, time=2020-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1708847, encodeId=855b1e0884779, content=<a href='/topic/show?id=ffca32501e6' target=_blank style='color:#2F92EE;'>#前列腺切除#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32501, encryptionId=ffca32501e6, topicName=前列腺切除)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbe731571573, createdName=1249898am25暂无昵称, createdTime=Fri May 10 21:23:00 CST 2019, time=2019-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1664860, encodeId=ae51166486072, content=<a href='/topic/show?id=c2ec311056b' target=_blank style='color:#2F92EE;'>#冷冻切片#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31105, encryptionId=c2ec311056b, topicName=冷冻切片)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bca925859708, createdName=41514495@qq.com, createdTime=Sat Oct 26 23:23:00 CST 2019, time=2019-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586135, encodeId=57871586135c2, content=<a href='/topic/show?id=38f8622191b' target=_blank style='color:#2F92EE;'>#根治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62219, encryptionId=38f8622191b, topicName=根治)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Apr 08 03:23:00 CST 2019, time=2019-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364215, encodeId=8ccb36421543, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Sat Apr 06 13:40:20 CST 2019, time=2019-04-06, status=1, ipAttribution=)]
    2019-04-08 zhaojie88
  5. [GetPortalCommentsPageByObjectIdResponse(id=1877139, encodeId=9a3a18e713929, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Sun Jan 12 20:23:00 CST 2020, time=2020-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1708847, encodeId=855b1e0884779, content=<a href='/topic/show?id=ffca32501e6' target=_blank style='color:#2F92EE;'>#前列腺切除#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32501, encryptionId=ffca32501e6, topicName=前列腺切除)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbe731571573, createdName=1249898am25暂无昵称, createdTime=Fri May 10 21:23:00 CST 2019, time=2019-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1664860, encodeId=ae51166486072, content=<a href='/topic/show?id=c2ec311056b' target=_blank style='color:#2F92EE;'>#冷冻切片#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31105, encryptionId=c2ec311056b, topicName=冷冻切片)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bca925859708, createdName=41514495@qq.com, createdTime=Sat Oct 26 23:23:00 CST 2019, time=2019-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586135, encodeId=57871586135c2, content=<a href='/topic/show?id=38f8622191b' target=_blank style='color:#2F92EE;'>#根治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62219, encryptionId=38f8622191b, topicName=根治)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Apr 08 03:23:00 CST 2019, time=2019-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364215, encodeId=8ccb36421543, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Sat Apr 06 13:40:20 CST 2019, time=2019-04-06, status=1, ipAttribution=)]
    2019-04-06 医者仁心5538

    学习了

    0

相关资讯

Radiology:MRI放射组学机器学习与ADC值在评价前列腺病变的价值

本研究旨在比较术前MRI阅片中比较双参数非对比放射组学机器学习(RML)平均表观扩散系数和放射科医生评价前列腺病变特点的差异。

Prostate Cancer P D:良性前列腺增生中摘除术与切除术效果和安全性评估

最近,有研究人员比较了前列腺经尿道摘除与切除术对治疗良性前列腺增生(BPH)的效果安全性情况。研究人员的元分析搜索的内容在2018年9月1日之前,所有包括的研究均为随机对照试验(RCTs)。研究人员根据国际前列腺症状评分(IPSS)、最大尿流率(Qmax)和生活质量(QoL)对效果进行了评价,并对围手术期资料及术后并发症也进行了评估。另外,研究人员还使用科克伦系统和GRADE系统对生活质量进行了评

Int J Impot Res:西地那非在前列腺切除术后勃起功能障碍中的相关分析

勃起功能障碍(ED)是根治性前列腺切除术的常见副作用,甚至在神经保留操作中也存在。为了减轻上述问题,被称为阴茎重建的计划已经开始进行。在上述问题中,最为常用的方法是在患者术后进行西地那非治疗或者PDE5抑制剂治疗。该方法基于一种理论,即这些药物可能能够增加阴茎氧化作用并提供抗凋亡因子(主要是NO和cGMP),从而保护阴茎组织在术后一段时期内神经功能减弱。预临床研究确认了西地那非在治疗ED中的作用,

Sci Rep:前列腺经直肠超声成像指导的活检中更有效的局部麻醉分析

最近,有研究人员利用网络元分析比较了各种控制前列腺活检(PBx)相关疼痛的局部麻醉的效果。研究人员对PubMed/Medline、Embase和Cochrane Library数据库的2018年3月之间的文献进行了搜索,并包括了47个随机对照试验,这些试验均在局部麻醉后使用了视觉模拟评分量表来对PBx相关的疼痛控制效果进行了评估。局部麻醉的方法包括了前列腺内局部麻醉(IPLA)、直肠内局部麻醉(I

Sci Rep:黑覆盆子及其鞣花酸和花青素成分对去势抵抗性前列腺癌细胞紫杉烷化疗的影响

癌症患者经常在治疗的过程中使用膳食补充剂,但是关于癌症化疗和膳食补充剂之间的互作关系了解甚少。黑覆盆子(BRB)具有抗癌症作用,但是在去势抵抗性前列腺癌(CRPC)化疗中的干涉作用仍旧还未评估。最近,有研究人员研究了是否BRB和其组成成分能够在培养基和移植的裸鼠中与多烯紫杉醇和卡巴他赛具有相互作用。研究发现,鞣花酸能够增加微管组装而BRB提取物却一直微管组装。鞣花酸、其代谢产物尿黄素A、BRB提取

盘点:前列腺相关疾病进展

前列腺是男性生殖器附属腺中最大的实质性器官。由前列腺组织和肌组织构成。前列腺癌是指发生在前列腺的上皮性恶性肿瘤。2004年WHO《泌尿系统及男性生殖器官肿瘤病理学和遗传学》中前列腺癌病理类型上包括腺癌(腺泡腺癌)、导管腺癌、尿路上皮癌、鳞状细胞癌、腺鳞癌。其中前列腺腺癌占95%以上,因此,通常我们所说的前列腺癌就是指前列腺腺癌。梅斯医学小编整理了近期前列腺疾病的研究进展,与大家一起分享学习!【

Baidu
map
Baidu
map
Baidu
map